Antiestrogen therapy for Hereditary hemorrhagic telangiectasia: A double-blind placebo-controlled clinical trial

Eitan Yaniv*, Michal Preis, Tuvia Hadar, Jacob Shvero, Miriam Haddad

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Antiestrogen therapy for Hereditary hemorrhagic telangiectasia: A double-blind placebo-controlled clinical trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Nursing and Health Professions

Agricultural and Biological Sciences

Veterinary Science and Veterinary Medicine